TuHURA Biosciences, Inc./NV cotiza a 1.81 USD y tiene una capitalización bursátil de $115M. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
TuHURA Biosciences, Inc., a clinical stage immuno-oncology company, that develops novel technologies for the treatment of cancer immunotherapies. The company's lead product candidate includes IFx2.0, an innate immune agonist designed to overcome primary resistance to checkpoint inhibitors. It is also preparing to initi…
| Periodo | 2026-11 | 2026-08 | 2026-05 | 2026-03 |
|---|---|---|---|---|
| Real | — | — | $-0.13 | $-0.16 |
| Estimado | $-0.13 | $-0.12 | $-0.11 | $-0.12 |
| Sorpresa | — | — | -18.2% | -33.3% |
| Métrica | HURA | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | — | 57.0% | — |
| Operating Margin | — | -38.6% | — |
| Net Margin | — | -33.6% | — |
| FCF Margin | — | -13.9% | — |
| ROE | -143.6% | -40.4% | -103.2% |
| ROA | -109.9% | -32.0% | -77.9% |
| Current Ratio | 0.78 | 2.84 | -2.06 |
| Debt / Equity | — | 0.28 | — |